Literature DB >> 3085134

Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat.

J D Salamone, M D Lalies, S L Channell, S D Iversen.   

Abstract

Pilocarpine administered in doses of 1.25-10.0 mg/kg (IP) produced a variety of mouth movements in the rat. The most frequent of these movements was a chewing behaviour, which increased up to a mean frequency of over 40 per min at the highest doses. Tongue protrusion and gaping also showed dose-dependent increases. Yawning tended to increase in some doses, though these increases were not significant, and yawning was relatively infrequent. Pre-treatment with scopolamine reduced these responses, while pre-treatment with methyl scopolamine did not. Injections of oxotremorine or arecoline, but not carbachol, produced dose-related increases in mouth movements similar to those produced by pilocarpine. These results suggest that mouth movements in the rat are caused by stimulation of central muscarinic receptors. This may prove to be an important behavioural sign of central cholinomimetic activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3085134     DOI: 10.1007/bf00178508

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Drugs affecting dopamine neurons and yawning behavior.

Authors:  E Mogilnicka; V Klimek
Journal:  Pharmacol Biochem Behav       Date:  1977-10       Impact factor: 3.533

2.  Is yawning a cholinergic response?

Authors:  R Urbá-Holmgren; R M González; B Holmgren
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

3.  Central effects of anticholergic drugs measured by the apomorphine gnawing test in mice.

Authors:  J Scheel-Krüger
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1970

4.  Neurotransmitters and CNS disease. Dementia.

Authors:  M N Rossor
Journal:  Lancet       Date:  1982-11-27       Impact factor: 79.321

5.  The Yawning elicited by alpha-melanocyte-stimulating hormone involves serotonergic-dopaminergic-cholinergic neuron link in rats.

Authors:  K Yamada; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

6.  A quantitative analysis of stereotyped gnawing induced by apomorphine.

Authors:  P Redgrave; P Dean; G Lewis
Journal:  Pharmacol Biochem Behav       Date:  1982-11       Impact factor: 3.533

Review 7.  The cholinergic hypothesis of geriatric memory dysfunction.

Authors:  R T Bartus; R L Dean; B Beer; A S Lippa
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

8.  Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.

Authors:  K Yamada; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

9.  Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats.

Authors:  N M Rupniak; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats.

Authors:  N M Rupniak; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  23 in total

1.  Quetiapine (Seroquel) shows a pattern of behavioral effects similar to the atypical antipsychotics clozapine and olanzapine: studies with tremulous jaw movements in rats.

Authors:  A Betz; K Ishiwari; A Wisniecki; N Huyn; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

2.  Plasma 1,8-cineole correlates with cognitive performance following exposure to rosemary essential oil aroma.

Authors:  Mark Moss; Lorraine Oliver
Journal:  Ther Adv Psychopharmacol       Date:  2012-06

3.  Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.

Authors:  A M Deveney; J L Waddington
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

4.  The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat.

Authors:  B R Stewart; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  On yawning and its functions.

Authors:  R Baenninger
Journal:  Psychon Bull Rev       Date:  1997-06

6.  Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behaviour.

Authors:  B R Stewart; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Role of calcium-independent phospholipase A2 in cortex striatum thalamus cortex circuitry-enzyme inhibition causes vacuous chewing movements in rats.

Authors:  Li-Yen Lee; Wei-Yi Ong; Akhlaq A Farooqui; Jean-Marc Burgunder
Journal:  Psychopharmacology (Berl)       Date:  2007-09-04       Impact factor: 4.530

8.  Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine.

Authors:  R E Steinpreis; P Baskin; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.

Authors:  P Collins; C L Broekkamp; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs.

Authors:  M S Cousins; W Wei; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.